105 related articles for article (PubMed ID: 14571356)
1. Risperidone-associated steatohepatitis and excessive weight-gain.
Holtmann M; Kopf D; Mayer M; Bechtinger E; Schmidt MH
Pharmacopsychiatry; 2003 Sep; 36(5):206-7. PubMed ID: 14571356
[TBL] [Abstract][Full Text] [Related]
2. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
Arman S; Sadramely MR; Nadi M; Koleini N
Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
[TBL] [Abstract][Full Text] [Related]
4. Risperidone in pervasive developmental disorders.
Erickson CA; Stigler KA; Posey DJ; McDougle CJ
Expert Rev Neurother; 2005 Nov; 5(6):713-9. PubMed ID: 16274329
[TBL] [Abstract][Full Text] [Related]
5. Weight development in patients treated with risperidone: a 5-year naturalistic study.
Neovius M; Eberhard J; Lindström E; Levander S
Acta Psychiatr Scand; 2007 Apr; 115(4):277-85. PubMed ID: 17355518
[TBL] [Abstract][Full Text] [Related]
6. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder.
Demb H; Valicenti-McDermott M; Navarro A; Ayoob KT
J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456
[No Abstract] [Full Text] [Related]
7. [Risperidone and edema: apropos of a case].
Masson M; Elayli R; Verdoux H
Encephale; 2000; 26(3):91-2. PubMed ID: 10951912
[No Abstract] [Full Text] [Related]
8. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
9. Long-acting risperidone in stable patients with schizoaffective disorder.
Mohl A; Westlye K; Opjordsmoen S; Lex A; Schreiner A; Benoit M; Bräunig P; Medori R
J Psychopharmacol; 2005 Sep; 19(5 Suppl):22-31. PubMed ID: 16144783
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
[TBL] [Abstract][Full Text] [Related]
11. [Glucose abnormalities in a 14-year old patient treated with a second generation antipsychotic].
Lauwers K; de Hert M; de Rijdt L; Peuskens J
Tijdschr Psychiatr; 2006; 48(4):331-5. PubMed ID: 16955998
[TBL] [Abstract][Full Text] [Related]
12. Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats.
Fell MJ; Neill JC; Marshall KM
Eur Neuropsychopharmacol; 2004 Oct; 14(5):385-92. PubMed ID: 15336300
[TBL] [Abstract][Full Text] [Related]
13. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
[TBL] [Abstract][Full Text] [Related]
14. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
[TBL] [Abstract][Full Text] [Related]
15. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.
Sahoo S; Mishra B; Akhtar S
Br J Clin Pharmacol; 2007 Nov; 64(5):715-6. PubMed ID: 17509037
[No Abstract] [Full Text] [Related]
17. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
18. Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report.
Theleritis CG; Papadimitriou GN; Papageorgiou CC; Dikeos DG; Masdrakis V; Kostoulas C; Psarros C; Soldatos CR
BMC Psychiatry; 2006 Sep; 6():37. PubMed ID: 16953883
[TBL] [Abstract][Full Text] [Related]
19. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
[No Abstract] [Full Text] [Related]
20. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study.
Hrdlicka M; Zedkova I; Blatny M; Urbanek T
Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
